Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans
- PMID: 11555793
- PMCID: PMC1274356
- DOI: 10.1086/323765
Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans
Abstract
Arginine:glycine amidinotransferase (AGAT) catalyzes the first step of creatine synthesis, resulting in the formation of guanidinoacetate, which is a substrate for creatine formation. In two female siblings with mental retardation who had brain creatine deficiency that was reversible by means of oral creatine supplementation and had low urinary guanidinoacetate concentrations, AGAT deficiency was identified as a new genetic defect in creatine metabolism. A homozygous G-A transition at nucleotide position 9297, converting a tryptophan codon (TGG) to a stop codon (TAG) at residue 149 (T149X), resulted in undetectable cDNA, as investigated by reverse-transcription PCR, as well as in undetectable AGAT activity, as investigated radiochemically in cultivated skin fibroblasts and in virus-transformed lymphoblasts of the patients. The parents were heterozygous for the mutant allele, with intermediate residual AGAT activities. Recognition and treatment with oral creatine supplements may prevent neurological sequelae in affected patients.
Figures
References
Electronic-Database Information
-
- GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for AGAT genomic DNA [accession number 1432573] and AGAT mRNA [accession number S68805])
-
- Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for AGAT [MIM 602360], GAMT [MIM 601240], and X-linked creatine transporter [MIM 300036])
References
-
- Bianchi MC, Tosetti M, Fornai F, Alessandrì MG, Cipriani P, De Vito G, Canapicchi R (2000) Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann Neurol 47:511–513 - PubMed
-
- Bodamer OA, Bloesch SH, Stöckler-Ipsiroglu S, O'Brien WE (2001) Analysis of guanidinoacetate and creatine by isotope dilution electrospray tandem mass-spectrometry. Clin Chim Acta 308:173–178 - PubMed
-
- Cecil KM, Salomons G, Ball WS, Wong B, Chuck G, Verhoeven NM, Jakobs C, DeGrauw TJ (2001) Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol 49:401–404 - PubMed
-
- Cotton RG (2000) Methods in clinical molecular genetics. Eur J Pediatr 159:S179–S182 - PubMed
-
- Cotton RGH, Scriver CR (1998) Proof of “disease causing” mutation. Hum Mutat 12:1–3 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
